Blog Tag: Boston Scientific

Boston Scientific closes acquisition of TAVI device company, Symetis

On March 30, 2017, Boston Scientific announced an agreement to acquire Symetis SA, a privately-held Swiss company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in cash.

The acquisition

Boston Scientific Announces Worldwide EMBLEM™ Study

Boston Scientific recently announced that it is launching a worldwide study for its EMBLEM™ MRI Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) device.  According to the press release, a multicenter trail of the device

NeuroTronik Closes $23.1 million Series B Round

NeuroTronik Closes $23.1 million Series B Round

NeuroTronik, a North Carolina based subsidiary of NeuroTronik LTD of Dublin, announced that it recently closed a $23.1 million Series B funding round. The press release noted that the round was led by contributions from Boston Scientific,

Potential Repeal of Medical Device Tax

With the upcoming Republican-dominated Presidency and Congress in 2017, the Affordable Care Act, or at least parts of it, look to be on the chopping block.  One of the changes that may be forthcoming is a repeal of the 2.3% medical device

Boston Scientific Acquires Cosman Medical

Boston Scientific Corporation announced today that it has acquired Cosmon Medical, Inc. for an undisclosed amount.

Cosman Medical is a privately held manufacturer of radiofrequency ablation (RFA) systems used to treat patients with

Abbott to Acquire St. Jude Medical for $25 Billion

A burst of potential acquisitions and consolidations occurred on April 28th in the medical device world, the largest being Abbott Laboratories‘ deal to acquire St. Jude Medical Inc.  The deal is for $25 billion dollars and would bring

Boston Scientific Launches AXIOS Stent and Delivery System

On March 22, 2016, Boston Scientific announced the launch of the AXIOS Stent and Electrocautery Enhanced Delivery
System.  According to its website, the stent and delivery system helps physicians treat complications relating to pancreatitis. 

Boston Scientific Files IPR Petitions Against Nevro

Boston Scientific Files IPR Petitions Against Nevro

Boston Scientific filed two petitions with the Patent Trial and Appeal Board on May 14, 2015 requesting inter partes review of Nevro’s U.S. Patent No. 8,359,102.    The petitions were assigned Case Nos. IPR2015-01203 and 

Boston Scientific Files Second IPR Petition Against UAB Patent

Boston Scientific Files Second IPR Petition Against UAB Patent

Boston Scientific Corporation (“Boston Scientific”) filed a petition with the Patent Trial and Appeal Board on April 10, 2015 requesting inter partes review of U.S. Patent No. 6,266,563 (“the ’563 Patent”).  The petition

Boston Scientific Files Petitions for Inter Partes Review of Three VSI Patents

Boston Scientific Files Petitions for Inter Partes Review of Three VSI Patents

On May 15 and 16, 2014, Boston Scientific Corporation and Boston Scientific Scimed, Inc. (collectively, “Boston Scientific”) filed a total of five petitions with the Patent Trial and Appeal Board requesting inter partes review

Boston Scientific to acquire the Interventional Division of Bayer AG

According to a Boston Scientific Corp. press release from May 15, 2014, the company has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 million. The transaction is expected to close in the

Mirowski Family Ventures Files Lawsuit Against Boston Scientific

Mirowski Family Ventures Files Lawsuit Against Boston Scientific

Last week, Mirowski Family Ventures, LLC filed a lawsuit against Boston Scientific Corp. and its wholly-owned subsidiaries Cardiac Pacemakers, Inc., Guidant LLC, and Guidant Sales LLC. According to the complaint, the defendants breached

Fighting Fire with Fire – the Medical Device Tax and Outsourcing

Fighting Fire with Fire – the Medical Device Tax and Outsourcing

Since its passage as part of the Affordable Care Act in 2010, the medical device tax has been hotly debated.  The 2.3% excise levied on total revenues may effectively preclude new entrants while hindering the growth of established companies. 

OrbusNeich Sues Boston Scientific In Ireland

OrbusNeich Sues Boston Scientific In Ireland

OrbusNeich Medical Inc. and its subsidiary, Orbus International B.V., announced on Friday a lawsuit against Boston Scientific Corp. in Ireland for alleged patent infringement.  According to the press release, the lawsuit

Federal Circuit Affirms $42 Million Award in Boston Scientific v. Cordis Corporation

Federal Circuit Affirms $42 Million Award in Boston Scientific v. Cordis Corporation

Boston Scientific has prevailed in the appeal of its lawsuit against Cordis Corporation.  Boston Scientific alleged in the lawsuit that Cordis’ 2.25 mm Cypher Sirolimus DES coronary stent infringed U.S. Pat. No. 5,922,021, entitled

New Suit Targets Rex Medical’s Vena Cava Filter

New Suit Targets Rex Medical’s Vena Cava Filter

EVM Systems, LLC has filed a new lawsuit targeting Rex Medical, L.P. and Argon Medical Devices, Inc.  The lawsuit alleges infringement of U.S. Patent No. 8,052,670, entitled “Medical Device With Slotted Memory Metal Tube.”  According

New Suit Targets C.R. Bard

C.R. Bard, Inc., and Bard Peripheral Vascular, Inc., are the latest targets of a series of lawsuits brought by LifeScreen Sciences LLC.  LifeScreen filed a patent infringement lawsuit in the District of Delaware on January 30 accusing